Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

    Encouraging grant applications for bioengineering innovations in cancer research and healthcare to enhance quality, speed, and accessibility.

    Browse similar grants
    Cancer Research Grants 2026Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission) | June 16, 2027 (New) | July 16, 2027 (Resubmission) | October 16, 2027 (New) | November 16, 2027 (Resubmission) | January 7, 2028 (Closing date)

    Funding Amounts: Up to $275,000 in direct costs over two years, with no more than $200,000 in any year

    Summary: Supports exploratory bioengineering research demonstrating the feasibility and potential utility of new or improved biomedical research and care capabilities.

    Key Information: Basic cancer biology studies and late-phase or randomized clinical trials are not responsive.


    Description

    The National Cancer Institute (NCI), part of NIH, supports exploratory/developmental bioengineering research through this R21 opportunity. Projects should demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, cost, or accessibility for biomedical research or clinical care. The program’s goals include identifying cancer risks, risk-reduction strategies, and cancer-causing factors, and developing cancer prevention mechanisms and interventions.

    Research may be hypothesis-driven, discovery-driven, developmental, or design-directed, drawing on engineering, physical sciences, biomedical sciences, mathematics, informatics, or machine learning. Multidisciplinary approaches, early technology development, and preliminary data collection are encouraged. Extensive background material or preliminary data are not necessary. Clinical trials are optional and may test functionality or validate performance in the intended setting, subject to the exclusions below.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.